Plain-English translation of NCT05579470 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a coaching and improvement strategy called NIATx can help clinics in Central Asia expand access to opioid agonist therapy — a proven medication that reduces cravings and helps people recover from opioid addiction. The researchers will work with clinics, healthcare staff, and patients in three countries to understand what barriers exist and how to overcome them so more people can get this life-saving treatment.
Central Asia is experiencing a growing HIV epidemic among people who inject drugs, and medication-assisted treatment is one of the most effective ways to prevent new infections and help people stay healthy. However, very few clinics in the region currently offer this treatment, and both patients and providers have concerns and misconceptions about it. This trial aims to remove those barriers and help more clinics successfully provide this treatment.
You likely qualify if…
You likely don't qualify if…
Depending on your role, you might complete a survey about barriers to treatment, join a focus group discussion with other patients or staff, or participate in an organizational assessment at your clinic. The research team will use this feedback to help clinics implement an improvement coaching program designed to make treatment more accessible and reduce stigma. Your participation helps shape better treatment services for your community.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Kazakhstan
Kyrgyzstan
Tajikistan